Correlation between high expression levels of jumonji domain-containing 4 and short survival in cases of colon adenocarcinoma
Creators
- 1. School of Pharmacy, National Defense Medical Center, Taipei (China)
- 2. Department of Otorhinolaryngology-Head and Neck Surgery, Tri-Service General Hospital, Taipei (China)
- 3. School of Medicine, Chung Shan Medical University, Taichung (China)
- 4. Department of Pathology, Changhua Christian Hospital, Changhua (China)
- 5. International Joint Center for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng, Henan (China)
- 6. Department of Biological Sciences, National University of Singapore (Singapore)
- 7. Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli (China)
Description
Highlights: • The play an important role of JMJD4 high expression in tumorgenesis of colon adenocarcinoma. • JMJD4 protein expression in colon adenocarcinoma was associated with histological grade and M-class. • The high expression of JMJD4 was significantly related with poor survival in patients with colon adenocarcinoma. • Cox proportional-hazards model analysis indicated JMJD4 could be a prognostic indicator for overall survival. In this study, we investigated the expression of jumonji domain-containing 4 (JMJD4) in colon adenocarcinoma (CA) look for evidences for future studies on clinical diagnostic and prognostic value. The immunohistochemical (IHC) reactivity of JMJD4 was assessed in human tissue microarrays using monoclonal antibodies. An initial investigation revealed that the expression of JMJD4 protein was significantly higher in tumor tissue of the colon and liver than in normal tissue. Upon further investigation, we observed significant positivity of JMJD4 between 59 paired samples from CA tissue and adjacent normal tissue. JMJD4 protein expression in CA differed significantly according to the histological grade and M-class (distant metastasis). We also determined that the mRNA or protein expression of JMJD4 was significantly associated with poor survival in patients with CA. Finally, univariate and multivariate analysis revealed that JMJD4 expression could be a prognostic indicator for patients with CA and may provide a new target for the development of novel therapies for the treatment of CA.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2018.07.061Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2018.07.061;
- PII
- S0006291X18315560;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 503
- Journal Issue
- 3
- Journal Page Range
- p. 1442-1449
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53022037
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CARCINOMAS; LARGE INTESTINE; LIVER; MESSENGER-RNA; PROTEINS
- Descriptors DEC
- BODY; DIGESTIVE SYSTEM; DISEASES; GASTROINTESTINAL TRACT; GLANDS; INTESTINES; NEOPLASMS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RNA
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.